Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Are mesenchymal stem cells still effective in acute GvHD management?
Ulu BU, Hindilerden IY, Yigenoglu TN, Tiryaki TO, Erkurt MA, Korkmaz G, Namdaroglu S, Aksoy E, Korkmaz S, Seyhan M, Yilmaz S, Besisik SK, Dal MS, Ulas T, Altuntas F. Ulu BU, et al. Among authors: namdaroglu s. Transfus Apher Sci. 2024 Dec 16;64(1):104051. doi: 10.1016/j.transci.2024.104051. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39721135
Management of mobilization failure in 2017.
Namdaroglu S, Korkmaz S, Altuntas F. Namdaroglu S, et al. Transfus Apher Sci. 2017 Dec;56(6):836-844. doi: 10.1016/j.transci.2017.11.017. Epub 2017 Nov 8. Transfus Apher Sci. 2017. PMID: 29153350
Convalescent plasma therapy in patients with COVID-19.
Altuntas F, Ata N, Yigenoglu TN, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Kınık K, Haznedaroglu İ, Yılmaz FM, Kılıç İ, Demircioğlu S, Yosunkaya A, Erkurt MA, Turgut B, Caglayan M, Celik O. Altuntas F, et al. Among authors: namdaroglu s. Transfus Apher Sci. 2021 Feb;60(1):102955. doi: 10.1016/j.transci.2020.102955. Epub 2020 Sep 19. Transfus Apher Sci. 2021. PMID: 33011076 Free PMC article.
Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients.
Yiğenoğlu TN, Başcı S, Şahin D, Ulaş T, Dal MS, Korkmaz S, Hacıbekiroğlu T, Namdaroğlu S, Erkurt MA, Turgut B, Altuntaş F. Yiğenoğlu TN, et al. Among authors: namdaroglu s. Transfus Apher Sci. 2021 Dec;60(6):103237. doi: 10.1016/j.transci.2021.103237. Epub 2021 Aug 17. Transfus Apher Sci. 2021. PMID: 34419356 Free PMC article. Review.
International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report.
Ozatli D, Giden AO, Erkurt MA, Korkmaz S, Basci S, Ulas T, Turgut B, Yigenoglu TN, Hacibekiroglu T, Basturk A, Dal MS, Namdaroglu S, Hindilerden F, Hacioglu SK, Cagliyan GA, Ilhan G, Kacmaz M, Uysal A, Merter M, Ekinci O, Dursun FE, Tekinalp A, Demircioglu S, Sincan G, Acik DY, Akdeniz A, Ucar MA, Yeral M, Ciftciler R, Teke HU, Umit EG, Karakus A, Bilen Y, Yokus O, Albayrak M, Demir C, Okan V, Serefhanoglu S, Kartı S, Ozkurt ZN, Eser B, Aydogdu I, Kuku I, Cagirgan S, Sonmez M, Ozet G, Altuntas F. Ozatli D, et al. Among authors: namdaroglu s. Transfus Apher Sci. 2023 Apr;62(2):103662. doi: 10.1016/j.transci.2023.103662. Epub 2023 Feb 24. Transfus Apher Sci. 2023. PMID: 36842884 Review.
What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?
Ulas T, Namdaroglu S, Hindilerden IY, Erkurt MA, Erer K, Yigenoglu TN, Tiryaki TO, Hidayet E, Korkmaz S, Ulu BU, Yilmaz S, Kaya E, Pepeler MS, Basturk A, Dal MS, Altuntas F. Ulas T, et al. Among authors: namdaroglu s. Transfus Apher Sci. 2024 Dec 17;64(1):104058. doi: 10.1016/j.transci.2024.104058. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39700842 Review.
Efficacy of Ruxolitinib in the management of chronic GVHD.
Giden AO, Erkurt MA, Hindilerden IY, Hidayet E, Berber I, Tiryaki TO, Zorlu T, Namdaroglu S, Sarici A, Aksoy E, Yildizhan E, Aydin MS, Korkmaz S, Dal MS, Ulas T, Altuntas F. Giden AO, et al. Among authors: namdaroglu s. Transfus Apher Sci. 2024 Dec 17;64(1):104053. doi: 10.1016/j.transci.2024.104053. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39708419
Is there a relationship between vitamin D levels and graft versus host disease?
Yigenoglu TN, Ulu BU, Namdaroglu S, Erkurt MA, Sahin R, Okumus N, Yilmaz S, Ceran F, Koca M, Hatipoglu U, Dal MS, Korkmaz S, Ulas T, Altuntas F. Yigenoglu TN, et al. Among authors: namdaroglu s. Transfus Apher Sci. 2024 Dec 16;64(1):104054. doi: 10.1016/j.transci.2024.104054. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39709787
The role of ruxolitinib in the management of acute GVHD.
Namdaroglu S, Hidayet E, Aydin MS, Erkurt MA, Berber I, Cinar OE, Ozet G, Yilmaz S, Apaydin M, Dal MS, Korkmaz S, Basturk A, Ulaş T, Altuntas F. Namdaroglu S, et al. Transfus Apher Sci. 2024 Dec 16;64(1):104055. doi: 10.1016/j.transci.2024.104055. Online ahead of print. Transfus Apher Sci. 2024. PMID: 39719750
A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study.
Tekgündüz E, Yılmaz M, Erkurt MA, Kiki I, Kaya AH, Kaynar L, Alacacioglu I, Cetin G, Ozarslan I, Kuku I, Sincan G, Salim O, Namdaroglu S, Karakus A, Karakus V, Altuntas F, Sari I, Ozet G, Aydogdu I, Okan V, Kaya E, Yildirim R, Yildizhan E, Ozgur G, Ozcebe OI, Payzin B, Akpinar S, Demirkan F. Tekgündüz E, et al. Among authors: namdaroglu s. Transfus Apher Sci. 2018 Feb;57(1):27-30. doi: 10.1016/j.transci.2018.02.012. Epub 2018 Feb 20. Transfus Apher Sci. 2018. PMID: 29503132
32 results